Catalog No.S1376 Synonyms: SH B 331,WL 70

For research use only.

Gestodene (SH B 331,WL 70) is a progestogen hormonal contraceptive.

Gestodene Chemical Structure

CAS No. 60282-87-3

Purity & Quality Control

Choose Selective Estrogen/progestogen Receptor Inhibitors

Other Estrogen/progestogen Receptor Products

Biological Activity

Description Gestodene (SH B 331,WL 70) is a progestogen hormonal contraceptive.

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 310.43


CAS No. 60282-87-3
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT02550977 Completed Drug: Gestodene/EE Patch (BAY86-5016) Contraception Bayer September 18 2015 Phase 2
NCT01260805 Completed Drug: Reference Drug|Drug: Test Drug Bioequivalence|Ethinylestradiol|Gestodene|Harmonet Pfizer September 2010 Phase 1
NCT01204190 Completed Drug: Gestodene/EE Patch (BAY86-5016) Contraception Bayer September 2010 Phase 2
NCT01083264 Completed Drug: Gestodene/EE Patch (BAY86-5016) Contraception Bayer October 2009 Phase 1
NCT00915915 Completed Drug: Ethinylestradiol/Gestodene (BAY86-5016) Contraception|Ovulation Inhibition Bayer June 2009 Phase 2

(data from, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Gestodene | Gestodene ic50 | Gestodene price | Gestodene cost | Gestodene solubility dmso | Gestodene purchase | Gestodene manufacturer | Gestodene research buy | Gestodene order | Gestodene mouse | Gestodene chemical structure | Gestodene mw | Gestodene molecular weight | Gestodene datasheet | Gestodene supplier | Gestodene in vitro | Gestodene cell line | Gestodene concentration | Gestodene nmr